Sphingomyelin derivatives modulate a multitude of cellular processes, including the regulation of [Ca 2+ ] i (the intracellular free calcium concentration). Previous studies have shown that these metabolites often inhibit calcium entry through VOCCs (voltageoperated calcium channels). In the present study, we show that, in pituitary GH 4 C 1 cells, C1P (C 2 -ceramide 1-phosphate) enhances calcium entry in a dose-dependent manner. The phospholipase C inhibitor U73122 attenuated the response. C1P invoked a small, but significant, increase in the formation of inositol phosphates. Pre-treatment of the cells with pertussis toxin was without an effect on the C1P-evoked increase in [Ca 2+ ] i . The effect of C1P was critically dependent on extracellular calcium, since no increase in [Ca 2+ ] i was observed when cells in a calcium-free buffer were stimulated with C1P. Furthermore, if the cells were retreated with 300 nM of the VOCC inhibitor nimodipine, the effect of C1P was almost totally abolished. In addition, ceramide 
INTRODUCTION
Sphingomyelin derivatives, i.e. sphingosines and ceramides, potently modulate a multitude of cellular events, including proliferation, differentiation and migration [1, 2] . Some of these derivatives, especially sphingosine, S1P (sphingosine 1-phosphate) and SPC (sphingosylphosphorylcholine), also have diverse effects on the regulation of [Ca 2+ ] i (the intracellular free calcium concentration) in both non-excitable and excitable cells. In nonexcitable cells, S1P and SPC mobilize sequestered calcium and activate calcium entry [2, 3] . Many of these effects are mediated by G-protein-coupled plasma membrane receptors for sphingolipids. Five S1P receptors have been identified so far, namely S1P 1−5 [2] , and in addition two SPC-specific receptors, OGR1 (ovarian cancer G-protein-coupled receptor 1) [4] and GPR4 (G-protein-coupled receptor 4) [5] . Sphingosine is a potent inhibitor of SOC entry (store-operated calcium entry) via inhibition of I CRAC (calciumrelease-activated calcium current) [6] . In addition to effects mediated by plasma membrane receptors, a putative intracellular receptor for sphingolipids, SCaMPER (sphingolipid calciumrelease mediating protein of the endoplasmic reticulum), has been cloned [7] . The physiological importance of this receptor is still Abbreviations used: BAPTA, bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid; C1P, C 2 -ceramide 1-phosphate; C 8 1P, C 8 -ceramide 1-phosphate; [Ca 2+ ] i , intracellular free calcium concentration; EDG, endothelial differentiation gene; fura 2/AM, fura 2 acetoxymethyl ester; (lyso)PA, (lyso)phosphatidic acid; OAG, 1-oleoyl-2-acetyl-sn-glycerol; PKC, protein kinase C; PLC, phospholipase C; P open , probability (of the VOCCs) being open; S1P, sphingosine 1-phosphate; SOC entry, store-operated calcium entry; SPC, sphingosylphosphorylcholine; TRH, thyrotropin-releasing hormone; VOCCs, voltage-operated calcium channels. 1 To whom correspondence should be addressed, at the Department of Biology, Å bo Akademi University (e-mail kid.tornqvist@abo.fi). 2 Present address: OrionPharma, Orionintie 1, 02200 Espoo, Finland.
not clear [2] . Sphingosine and SPC potently attenuate VOCCs (voltage-operated calcium channels) and ryanodine receptors in excitable cells, such as cardiac and pituitary cells [3, 8, 9] . Ceramides, which are produced prior to sphingosine when sphingomyelin is hydrolysed, have been shown in a few reports to invoke changes in [Ca 2+ ] i [10, 11] . Furthermore, C 8 -ceramide attenuates SOC entry in non-excitable cells [12] [13] [14] . C 8 -ceramide also inhibits the L-type VOCCs in pinealocytes [15] and attenuates K + channels [16, 17] .
In addition to ceramide, C1P (C 2 -ceramide 1-phosphate) is a putative modulator of cellular functions (e.g. see [1] ), although little is known with regard to its physiological significance. C1P enhances DNA synthesis in fibroblasts, although the mechanism of action is still not known [18, 19] . According to these reports, C1P does not modulate [Ca 2+ ] i . On the other hand, recent results suggest that C1P may attenuate phenylephrine-evoked changes in [Ca 2+ ] i in rat aortic smooth muscle [20] . In a recent study, we have shown that C1P evokes a potent increase in [Ca 2+ ] i in thyroid FRTL-5 cells, which seems to be due to an increased level of both inositol 1,4,5-trisphosphate and intracellular S1P [21] . However, C1P may be considered a sphingoid form of PA (phosphatidic acid). Furthermore, PA and lysoPA bind to Edg2, Edg4 and Edg7, receptors that are closely related structurally to the sphingolipid receptors [22, 23] . Furthermore, lysoPA, at least, is a weak agonist for the S1P 1 receptor [24] . The GH 4 C 1 cells express at least the sphingolipid receptor S1P 2 [25] . Thus we considered it to be of importance to investigate the effects of C1P on the regulation of [Ca 2+ ] i . Our results have shown that C1P evoked an entry of extracellular calcium into GH 4 C 1 cells by a PKC (protein kinase C)-mediated activation of VOCCs.
MATERIALS AND METHODS

Materials
Culture medium, serum and hormones were purchased from Gibco (Grand Island, NY, U.S.A.), Biological Industries (Beth Haemek, Israel) and Sigma (St Louis, MO, U.S.A.). Culture dishes were obtained from Falcon Plastics (Oxnard, CA, U.S.A.). C1P and C 8 1P (C 8 -ceramide 1-phosphate) were purchased from Avanti Lipids (Alabaster, AL, U.S.A.). Pertussis toxin, lysoPA, GF109203X, U73122 and U73343, OAG (1-oleoyl-2-acetyl-snglycerol) and PMA were all purchased from Sigma. Amprep ® mini-columns (SAX, 100 mg; RPN 1908) and myo-[ • C, as described previously [26] . Before an experiment, cells from one culture dish were harvested with PBS containing 0.05 mM EDTA and plated on to 100 mm culture dishes. The cells were grown for 7-9 days, with two changes of the culture medium. Fresh medium was always added to the cells 24 h prior to an experiment.
Measurement of [Ca 2+ ] i in GH 4 C 1 cells: cell-suspension experiments
Cells were harvested with Hepes-buffered salt solution (HBSS, containing in mM: NaCl, 118; KCl, 4.6; CaCl 2 , 1; glucose, 10; and Hepes, 20 mM, pH 7.4) lacking CaCl 2 , but containing 0.05 mM EDTA. After washing the cells three times with HBSS buffer containing 1 mM CaCl 2 , the cells were incubated with fura 2/AM (final concentration 2 µM) for 30 min at 37
• C. Following the loading period, the cells were incubated for at least 20 min to ensure complete cleavage of the AM group from fura 2. After washing the cells once more, the cells were added to a quartz cuvette, kept at 37
• C and stirred throughout the experiment. Fluorescence was measured with a Hitachi F2000 fluorimeter (Hitachi, Tokyo, Japan). The excitation wavelengths were 340 nm and 380 nm, and emission was measured at 510 nm. The signal was calibrated by the addition of 1 mM CaCl 2 and 10 % (v/v) Triton X-100 to obtain maximal fluorescence (R max ). Then, extracellular Ca 2+ was chelated with 5 mM EGTA and the pH was elevated above 8.3 with Tris base to obtain minimum fluorescence (R min ). [Ca 2+ ] i was calculated as described by Grynkiewicz et al.
[27] using a computer program designed for the fluorimeter, with a K d value of 224 nM for fura 2.
Calcium-imaging experiments
Cells from one 100 mm cell culture dish were harvested using 0.02 % EDTA solution, and plated on to polylysine-coated round coverslips (diameter 2.5 cm). After 2-4 days of culture, the cells were incubated with fura 2/AM (final concentration 4 µM) for 30 min at 37 • C. Following the loading period, the cells were incubated for at least 20 min to ensure complete cleavage of the AM-group from fura 2. After washing the cells once, the coverslip was mounted on a holder that was mounted on an Axiovert 35-inverted microscope with a Fluor 40× objective, and perfused with HBSS. The excitation filters were set at 340 nm and 380 nm, and the excitation light was obtained using an XBO 75W/2 xenon lamp. Emission was measured at 510 nm. The shutter was controlled by a Lambda 10-2 control device (Sutter Instruments, Novato, CA, U.S.A.). Fluorescence images were collected with a SensiCam 12BIT charge-coupled-device (CCD) camera (PCO/CD Imaging, Kelheim, Germany). Images were taken every 2.6 s to avoid bleaching, and the images were processed using Axon Imaging Workbench 2.1 software (Axon Instruments, Foster City, CA, U.S.A.). The results are given as the 340 nm/380 nm ratio. The experiments were performed at 37
• C.
Measurement of inositol phosphates
The cells were pre-incubated with myo-[ 3 H]inositol (10 µCi/ 100 mm dish) for 48 h. After harvesting, the cells were suspended in HBSS. The cells were first incubated for 10 min at 37
• C, then with HBSS containing 10 mM LiCl for 10 min, and finally the cells were stimulated with either vehicle or C1P (final concentration 10 µM) for 30 s at 37
• C. Inositol phosphates were extracted using 10 % (v/v) HClO 4 , and then separated using Amprep ® (SAX) mini-columns [28] . The radioactivity of the samples was measured by liquid scintillation counting.
Measurement of cellular cAMP
The cells were harvested as described for the calcium experiments, and were pre-incubated in HBSS for 20 min in the presence of 0.3 mM isobutylmethylxanthine (to inhibit phosphodiesterase activity). Then, aliquots of cells (0.5 × 10 6 cells/tube) were stimulated with 10 µM C1P. After 15 min, the reaction was stopped with 50 µl of HClO 4 added to a final concentration of 0.5 M. The samples were neutralized by KOH, and the cAMP concentrations were determined using a protein binding method [29] .
Patch-clamp experiments
The studies were performed using the patch-clamp technique in the whole-cell mode and in the cell-attached mode [30] . The electrodes were made from GC150TF glass capillaries (Harvard Apparatus, Edenbridge, Kent, U.K.). In the whole-cell experiments, the electrodes had a resistance of 3-5 M when filled with Hepes-buffered salt solution I (HBSS-I buffer, containing in mM: CsCl, 90; MgCl 2 , 5; CaCl 2 , 2.5; MgATP 2− , 4; GTP, 0.1; BAPTA, 10; glucose, 10; tetraethylammonium chloride, 20; leupeptin, 0.1; creatine phosphate, 6; creatine phosphokinase, 20 units/ml; Hepes, 20; pH 7.2, adjusted with CsOH). Leak and capacitative currents in the whole-cell recordings were compensated for by the P/4 routine from a holding potential of − 80 mV. The access resistance was 7-15 M . No series resistance compensation was made. Before an experiment, the coverslips were attached to a perfusion chamber, and the cells were perfused with HBSS-Ba (containing in mM: BaCl 2 , 60; tetraethylammonium chloride, 75; glucose, 10; Hepes, 10; pH 7.4, adjusted with tetraethylammonium hydroxide) with or without the appropriate concentrations of C1P using a gravity perfusion system. The recordings were made with an EPC-9 patch-clamp amplifier (HEKA Elektronik, Lambrecht/ Pfalz, Germany) at room temperature (22 • C). The cells were held at − 80 mV. A stock solution of C1P (10 mM) was made in DMSO. The final concentration of the solvent did not exceed 0.2 %. This concentration of the solvent did not have any effects on VOCCs in GH 4 C 1 cells. Data analysis of all experiments was made using the Pulsefit program (HEKA Electronik, Lambrecht, Germany).
In the cell-attached single-channel recordings, the cells were bathed in a high-potassium HBSS buffer (HBSS-K, containing in mM: KCl, 140; MgCl 2 , 1.13; glucose, 10; Hepes, 10; pH 7.2, adjusted with KOH) to abolish the membrane potential. In these experiments, the pipettes were filled with HBSS-BaII buffer (containing in mM: BaCl 2 , 110; tetraethylammonium chloride, 10; Hepes, 10; pH 7.2, adjusted with tetraethylammonium hydroxide), and had a resistance of 10-20 M . Leak and capacitive currents in the single-channel experiments were subtracted and compensated for in all recordings. Data analysis of all experiments was made using the TAC and TACFit programs (Heka Elektronik).
Statistics
The results are expressed as the means + − S.E.M. Each experiment was repeated at least three times. Statistical analysis was made by using Student's t test for paired observations. When three or more means were tested, one way analysis of variance was used, followed by Bonferroni's multiple comparison test. (Figure 1) . The increase appeared to be mediated by calcium entry through VOCCs, as the C1P-evoked increase in [Ca 2+ ] i was substantially attenuated in cells incubated with 300 nM nimodipine (Figure 1) .
RESULTS
Effects
We tested whether the effect of C1P on [Ca 2+ ] i was sensitive to pertussis toxin, but observed that the increase in [Ca 2+ ] i evoked with 10 µM C1P in cells pre-treated with pertussis toxin (50 ng/ml for 24 h) was indistinguishable from that observed in control cells (Figure 1 ). Thus the effect of C1P was not mediated by a G i /G o protein. However, when the cells were pre-treated for 2 min with 5 µM of the PLC (phospholipase C) inhibitor U73122, the C1P-evoked increase in [Ca 2+ ] i was attenuated (Figure 1 ). The inactive analogue U73343 was without an effect. In addition, stimulating the cells with 10 µM C1P for 30 s evoked a small, but significant (P < 0.05) increase in the formation of inositol phosphates (Figure 1 ). In cells pre-treated with 1 µM thapsigargin for 15 min to deplete intracellular calcium stores, C1P evoked an increase in [Ca 2+ ] i that was of a similar magnitude to that seen in control cells (Figure 1 In control experiments using 10 µM C 8 1P, we also observed an increase in [Ca 2+ ] i (162 + − 23 nM; n = 4), but the response was much slower in onset compared with that for C 2 1P (Figure 2) . As with C1P, the increase evoked by C 8 1P was attenuated by nimodipine.
To (Figure 3) . The different response of individual cells to exogenous stimulation is typical for GH 4 C 1 cells [32] . In the presence of 300 nM nimodipine, we never observed an increase in [Ca 2+ ] i in response to C1P (Figure 3) .
Next, we wanted to compare the effects of C1P with that of other sphingolipid derivatives. Our previous study showed that ceramide, S1P, sphingosine and SPC did not increase [Ca 2+ ] i in GH 4 C 1 cells [31] . However, as lysoPA binds to the same family of Edg receptors as S1P, we wanted to investigate the effects of lysoPA on ] i (168 + − 8 nM) that was blocked by 300 nM nimodipine. In control experiments, we observed that stimulating thapsigargin-treated cells with 100 nM TRH (thyrotropin-releasing hormone) also evoked a nimodipinesensitive entry of calcium (216 + − 32 nM). We thus conclude that depletion of intracellular calcium stores does not abolish receptorinvoked activation of the VOCCs (see [33] ).
Action of C1P on VOCCs in GH 4 C 1 cells
To characterize the mechanism of action of C1P on [Ca 2+ ] i , we investigated the effect of C1P on VOCCs using patch-clamp. When patch-clamp was used in the whole-cell mode, we obtained a rapid rundown of the VOCCs (results not shown), similar to that in a previous study [8] . In cells perfused with 10 µM C1P, the rundown was consistently slower compared with control cells ( Figure 5) . A significant effect was observed at 10 µM only, due to the fact that the experiments were performed at room temperature. When control calcium experiments were performed at room temperature, the cells also had to be stimulated with 10 µM C1P to obtain an increase in [Ca 2+ ] i (results not shown). As several transport mechanisms for lipids may exist in cells, we wanted to investigate whether the effect of C1P was mediated by cellular uptake of C1P. However, in experiments where the pipette solution contained 10 µM C1P, we were unable to observe any difference in the I/I max relationship compared with control cells (results not shown). Thus the effect of C1P was not due to an intracellular effect of C1P.
We have recently shown that C1P increases the production of S1P in thyroid cells [21] . Thus it is possible that the effect of C1P was mediated by the formation of intracellular S1P. To test this possibility, we dialysed the cells with 30 µM S1P in the pipette solution. In these experiments we could not observe an enhanced calcium current in cells dialysed with S1P, compared with control cells (results not shown). Thus the effect of C1P was not mediated by the formation of intracellular S1P. To characterize further the effects of C1P, we performed oncell patch-clamp experiments. In our hands, the patches were very silent, and showed very few openings of the VOCCs, probably due to the fact that the experiments were performed at room temperature. Thus the probability of the VOCCs being open (P open ) was very low. However, during the course of the experiments we were able to obtain an increase in P open (P < 0.05) of the VOCCs in cells in which the pipette contained 10 µM C1P (P open 0.06 + − 0.01), compared with control cells (P open 0.01 + − 0.003; Figure 6 ). These results thus suggest that the C1P-evoked increase in [Ca 2+ ] i is due to an enhanced calcium entry through VOCCs.
Previous studies on the regulation of [Ca 2+ ] i in GH 4 C 1 cells have shown that agonists activating the PLC-signalling pathway activate calcium entry through VOCCs by a mechanism dependent on the activation of PKC, and that stimulation of the cells with OAG or PMA also increased [Ca 2+ ] i [34] . When we stimulated our cells with 10 µM OAG, [Ca 2+ ] i increased by 44 + − 5 nM. The increase was attenuated by nimodipine. Similar results were obtained with 30 nM PMA. We thus pre-treated the cells with The cells were loaded with fura 2, and the experiments were performed as described in the Materials and methods section. The effect of 10 µM C1P on [Ca 2+ ] i in three representative cells is shown (a-c). For comparison, the cells were stimulated with 100 mM K + (KCl). A total of 16 cells were investigated. In (c), the cell was incubated in the presence of 300 nM nimodipine. A total of 11 cells were investigated.
200 nM PMA for 24 h to down-regulate PKC. In these experiments, the C1P-evoked increase in [Ca 2+ ] i was attenuated (Figure 7) . Furthermore, in cells treated for 2 min with 10 µM of the PKC inhibitor GF109203X, the C1P-evoked increase in [Ca 2+ ] i was attenuated. We next performed patch-clamp experiments in the on-cell mode with cells pre-treated with 200 nM PMA for 24 h to down-regulate PKC. In these experiments, P open was extremely low, and 10 µM C1P was unable to enhance P open (Figure 7) . Our results thus suggest that, in GH 4 C 1 cells, C1P enhances calcium entry through VOCCs by a mechanism dependent on activation of PKC.
DISCUSSION
In the present paper, we have described the effects of C1P on calcium fluxes in pituitary GH 4 C 1 cells, and show that C1P enhances calcium entry through VOCCs. This is a remarkable observation, because most sphingolipids previously tested on excitable cells inhibit VOCCs. In cardiac cells, brain cells and pituitary GH 4 C 1 cells, both sphingosine and SPC inhibit VOCCs [8, 9, 35] . In the sarcoplasmic reticulum, sphingosine inhibits the ryanodine receptor [36] . Furthermore, in pinealocytes ceramide inhibits VOCCs [15] . Our previous study showed that ceramide slightly attenuated high potassium-evoked calcium entry in GH 4 C 1 cells [31] . Thus C1P provides a novel mechanism of action of sphingolipids on VOCCs. At present, there are only a few reports on the cellular effects of C1P. In fibroblasts, C1P is a potent mitogen, although the mechanism of action is currently not understood [18, 19] . C1P also activates phospholipase A 2 , and enhances the release of arachidonic acid [37] . In osteoblastic cells, C1P stimulates proliferation by a mitogen-activated-protein-kinase-dependent mechanism [38] . Furthermore, C1P has been shown to inhibit the phenylephrineinvoked changes in [Ca 2+ ] i in rat aortic smooth muscle, and to relax these arteries after a phenylephrine-invoked contraction [20] . In the brain, a role for C1P is implicated by the findings that a ceramide kinase and a C1P phosphatase have been identified in membranes of synaptic vesicles [39, 40] . A role for C1P during neutrophil phagocytosis and liposome fusion has also been indicated [41] . However, in all these reports, the mechanism of action of C1P was not determined.
Our results suggest that C1P enhances calcium entry through VOCCs by enhancing the probability of the channels being open. Furthermore, this effect seems to involve activation of the PLCsignalling pathway, since the effect of C1P on the VOCCs was attenuated by U73122 and inhibition of PKC. We also showed that C1P enhanced the formation of inositol phosphates.
The GH 4 C 1 cells express the S1P 2 receptor [25] . Thus we cannot exclude the possibility that C1P could modulate [Ca 2+ ] i and the VOCCs by interacting with this receptor. However, it is interesting to note that S1P, which binds to the S1P 2 receptor with high affinity, is without an effect on either [Ca 2+ ] i or VOCCs in GH 4 C 1 cells [31] . Binding experiments in cells overexpressing the receptors for S1P have also shown that C1P competes poorly with S1P for binding to the receptors [42, 43] . Thus C1P is probably not acting through the S1P-sensitive receptors known at present. Theoretically, C1P could interact with the lysoPA receptors Edg2, Edg4 and Edg7, which are structurally closely related to the sphingolipid receptors S1P 1 , S1P 3 and S1P 2 [22, 23] . In our experiments, however, the effects of lysoPA on [Ca 2+ ] i were strikingly different from that of C1P. First, lysoPA evoked a small, but distinct increase in [Ca 2+ ] i in cells incubated in a calcium-free buffer. Furthermore, in the presence of nimodipine, lysoPA evoked a substantial increase in [Ca 2+ ] i , very similar to that of other agonists acting through a G-protein-coupled mechanism (e.g. TRH; see [33] stores. This increase in [Ca 2+ ] i was sensitive to nimodipine. One possibility is thus that C1P acts through some as-yet-unknown receptor. It is clear that C1P does not evoke a non-specific permeabilization of the plasma membrane, because the C1P-evoked increase in [Ca 2+ ] i obtained with all doses of C1P tested always was abrogated by nimodipine. Sphingomyelin is present predominantly in the outer leaflet of the plasma membrane [44] , and ceramide kinase is associated with the plasma membrane [40, 41] . It is thus conceivable that high concentrations of C1P can be formed in the plasma membrane, where it could efficiently interact with several proteins, e.g. channel proteins. Thus our observation that C1P modulates VOCCs may have important consequences for the cells. First, the enhanced entry of calcium can have a beneficial effect on the proliferation of the cells. An enhanced proliferation was also observed in fibroblasts stimulated with C1P [18, 19] . Secondly, an increased influx of calcium enhances secretion from secretory cells, including GH 4 C 1 cells [33] , and may potently enhance hormone gene expression [45] . Furthermore, earlier studies have shown that the membrane-associated ceramide kinase in synapses is activated in a calcium-dependent manner [40] . A possibility is that C1P forms a part of the mechanisms regulating calcium entry, and thus secretion, in cells.
In conclusion, the effects of C1P on [Ca 2+ ] i have been characterized in GH 4 C 1 cells. The results showed that C1P enhanced calcium entry through VOCCs. Thus our results reveal a novel mechanism of action of sphingolipid derivatives on cellular calcium homoeostasis.
